# Erythropoietin to Improve Critical Care Patient Outcomes

> **NCT05080049** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Angers** · enrollment: 42 (actual)

## Conditions studied

- Anemia
- Intensive Care

## Interventions

- **DRUG:** Erythropoietin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05080049
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-28
- **Primary completion:** 2022-09-02
- **Final completion:** 2022-12-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05080049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05080049, "Erythropoietin to Improve Critical Care Patient Outcomes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05080049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*